hydroxyzine

hye-DROX-i-zeen

Therapeutic Classification: antianxiety agents, sedative/hypnotics

Pharmacologic Classification: antihistamines

BEERS REMS

Anxiety.
Preoperative sedation.
Nausea and vomiting.
Pruritus.
Urticaria.

Acts as a CNS depressant at the subcortical level of the CNS.
Has anticholinergic, antihistaminic, and antiemetic properties.
Blocks histamine-1 receptors.

Therapeutic effects:

Sedation.
Relief of anxiety.
Decreased nausea and vomiting.
Decreased allergic symptoms associated with release of histamine, including pruritus and urticaria.

Absorption: Well absorbed following oral and IM administration.

Distribution: Unknown.

Metabolism/Excretion: Completely metabolized by the liver; eliminated in the feces via biliary excretion.

Half-Life: 3 hr.

(sedative, antiemetic, antipruritic effects)

ROUTE	ONSET	PEAK	DURATION
PO	15–30 min	2–4 hr	4–6 hr
IM	15–30 min	2–4 hr	4–6 hr

Contraindicated in:

Hypersensitivity;
QT interval prolongation;
OB: Pregnancy;
Lactation: Lactation.

Use Cautiously in:

Severe hepatic impairment;
Congenital long QT syndrome, family history of long QT syndrome, recent MI, HF, hypokalemia, hypomagnesemia, bradycardia, or concurrent use of antiarrhythmics;
Pedi: Injection contains benzyl alcohol, which can cause potentially fatal gasping syndrome in neonates;
Geri: Appears on Beers list. ↑ risk of anticholinergic adverse reactions in older adults, including falls, delirium, and dementia. Avoid use in older adults.

CV: QT interval prolongation, TORSADES DE POINTES

Derm: acute generalized exanthematous pustulosis, flushing, rash

GI: dry mouth, bitter taste, constipation, nausea

GU: urinary retention

Local: pain (at IM site), abscesses at IM sites

Neuro: drowsiness, agitation, ataxia, dizziness, headache, weakness

Resp: wheezing

Drug-drug:

Additive CNS depression with other CNS depressants, including alcohol, antidepressants, antihistamines, opioid analgesics, and sedative/hypnotics.
Concurrent use of QT interval prolonging medications may ↑ risk of QT interval prolongation and torsades de pointes.
Additive anticholinergic effects with other drugs possessing anticholinergic properties, including antihistamines, antidepressants, atropine, haloperidol, phenothiazines, quinidine, and disopyramide.
Can antagonize the vasopressor effects of epinephrine.

Drug-Natural Products:

Kava-kava, valerian, or chamomile can ↑ CNS depression.
↑anticholinergic effects with angel’s trumpet, jimson weed, and scopolia.

PO (Adults ): Antianxiety: 25–100 mg 4 times/day, not to exceed 600 mg/day. Preoperative sedation: 50–100 mg single dose. Antipruritic: 25 mg 3–4 times daily.
PO (Children ): 2 mg/kg/day divided every 6–8 hr.
IM (Adults ): Preoperative sedation: 25–100 mg single dose. Antiemetic, adjunct to opioid analgesics: 25–100 mg every 4–6 hr as needed.
IM (Children ): 0.5–1 mg/kg every 4–6 hr as needed.

(Generic available)

Tablets: 10 mg; 25 mg; 50 mg
Capsules: 10 mg; 25 mg; 50 mg; 100 mg
Syrup: 10 mg/5 mL
Solution for injection: 25 mg/mL; 50 mg/mL

Assess sedation levels and monitor for oversedation or confusion; provide safety precautions as indicated (side rails up, bed in low position, call light within reach, bed alarms, supervision of ambulation and transfer). Geri: Older adults are more sensitive to CNS and anticholinergic effects (delirium, acute confusion, dizziness, dry mouth, blurred vision, urinary retention, constipation, tachycardia). Monitor for drowsiness, agitation, oversedation, and other systemic side effects. Assess falls risk and implement prevention strategies.
Anxiety: Assess mental status (orientation, mood, and behavior).
Nausea and Vomiting: Assess degree of nausea and frequency and amount of emesis.
Pruritus: Assess degree of itching and character of involved skin.

Lab Test Considerations:

May cause false-negative skin test results using allergen extracts. Discontinue hydroxyzine at least 72 hr before test.

Do not confuse hydroxyzine with hydralazine, hydrochlorothiazide, hydromorphone, or hydroxyurea.
PO: Tablets may be crushed and capsules opened and administered with food or fluids for patients having difficulty swallowing.
IM: Administer only IM deep into well-developed muscle; preferably the upper outer quadrant of the buttock in adults or the midlateral thigh in adults and children. Aspirate to avoid inadvertent injection into blood vessels. Injection is extremely painful. Do not use deltoid site. Significant tissue damage, necrosis, and sloughing may result from SUBQ or intra-arterial injections. Hemolysis may result from IV injections. Rotate injection sites frequently.

Explain the purpose and side effects of hydroxyzine. Instruct patient to take as directed. Take missed doses as soon as remembered unless it is almost time for next dose; do not double doses. Do not share medication with others, even if they have similar symptoms; may be harmful. Advise patient to read Patient Information before starting and with each Rx refill in case of changes.
May cause drowsiness or dizziness. Caution patient to avoid driving and other activities requiring alertness until response to medication is known. Geri: Warn patients or caregivers that older adults are at ↑ risk for CNS effects and falls.
Advise patient to notify health care provider of all Rx or OTC medications, vitamins, or herbal products being taken and to consult with health care provider before taking other medications. Advise patient to avoid concurrent use of alcohol or other CNS depressants with this medication.
Inform patient that frequent mouth rinses, good oral hygiene, and sugarless gum or candy may help ↓ dry mouth. If dry mouth persists for >2 wk, consult dentist about saliva substitute.
Rep: Advise women of reproductive potential to avoid use during early pregnancy or use effective contraception and to avoid breastfeeding during therapy. Instruct to notify health care provider if pregnancy is planned or suspected or if breastfeeding.

Decrease in anxiety.
Relief of nausea and vomiting.
Decreased allergic symptoms associated with release of histamine, including pruritus and urticaria.
Sedation when used as a sedative/hypnotic.

Vistaril

Atarax

NDC Code

0093- Teva Pharmaceuticals USA, Inc.
- 0093-5060- Hydroxyzine Hydrochloride
  - 0093-5060-01- 100 TABLET, FILM COATED in 1 BOTTLE (0093-5060-01)

0093- Teva Pharmaceuticals USA, Inc.
- 0093-5060- Hydroxyzine Hydrochloride
  - 0093-5060-05- 500 TABLET, FILM COATED in 1 BOTTLE (0093-5060-05)

0093- Teva Pharmaceuticals USA, Inc.
- 0093-5061- Hydroxyzine Hydrochloride
  - 0093-5061-01- 100 TABLET, FILM COATED in 1 BOTTLE (0093-5061-01)

0093- Teva Pharmaceuticals USA, Inc.
- 0093-5061- Hydroxyzine Hydrochloride
  - 0093-5061-05- 500 TABLET, FILM COATED in 1 BOTTLE (0093-5061-05)

0093- Teva Pharmaceuticals USA, Inc.
- 0093-5061- Hydroxyzine Hydrochloride
  - 0093-5061-10- 1000 TABLET, FILM COATED in 1 BOTTLE (0093-5061-10)

0093- Teva Pharmaceuticals USA, Inc.
- 0093-5062- Hydroxyzine Hydrochloride
  - 0093-5062-01- 100 TABLET, FILM COATED in 1 BOTTLE (0093-5062-01)

0093- Teva Pharmaceuticals USA, Inc.
- 0093-5062- Hydroxyzine Hydrochloride
  - 0093-5062-05- 500 TABLET, FILM COATED in 1 BOTTLE (0093-5062-05)

0121- PAI Holdings, LLC dba PAI Pharma
- 0121-1034- Hydroxyzine Hydrochloride
  - 0121-1034-16- 473 mL in 1 BOTTLE (0121-1034-16)

0404- Henry Schein, Inc.
- 0404-9877- Hydroxyzine Hydrochloride
  - 0404-9877-01- 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9877-01) / 1 mL in 1 VIAL, SINGLE-DOSE

0404- Henry Schein, Inc.
- 0404-9878- Hydroxyzine
  - 0404-9878-02- 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9878-02) / 2 mL in 1 VIAL, SINGLE-DOSE

0517- American Regent, Inc.
- 0517-4201- Hydroxyzine Hydrochloride
  - 0517-4201-25- 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-4201-25) / 1 mL in 1 VIAL, SINGLE-DOSE (0517-4201-01)

0517- American Regent, Inc.
- 0517-5601- Hydroxyzine Hydrochloride
  - 0517-5601-25- 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-5601-25) / 1 mL in 1 VIAL, SINGLE-DOSE (0517-5601-01)

0517- American Regent, Inc.
- 0517-5602- Hydroxyzine Hydrochloride
  - 0517-5602-25- 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-5602-25) / 2 mL in 1 VIAL, SINGLE-DOSE (0517-5602-01)

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8082- Hydroxyzine hydrochloride
  - 0615-8082-05- 15 TABLET in 1 BLISTER PACK (0615-8082-05)

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8082- Hydroxyzine hydrochloride
  - 0615-8082-28- 28 TABLET in 1 BLISTER PACK (0615-8082-28)

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8082- Hydroxyzine hydrochloride
  - 0615-8082-39- 30 TABLET in 1 BLISTER PACK (0615-8082-39)

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8563- Hydroxyzine hydrochloride
  - 0615-8563-39- 30 TABLET in 1 BLISTER PACK (0615-8563-39)

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8564- Hydroxyzine hydrochloride
  - 0615-8564-39- 30 TABLET in 1 BLISTER PACK (0615-8564-39)

0904- Major Pharmaceuticals
- 0904-6617- Hydroxyzine Hydrochloride
  - 0904-6617-61- 100 BLISTER PACK in 1 CARTON (0904-6617-61) / 1 TABLET, FILM COATED in 1 BLISTER PACK

0904- Major Pharmaceuticals
- 0904-6618- Hydroxyzine Hydrochloride
  - 0904-6618-61- 100 BLISTER PACK in 1 CARTON (0904-6618-61) / 1 TABLET, FILM COATED in 1 BLISTER PACK

0904- Major Pharmaceuticals
- 0904-7377- Hydroxyzine hydrochloride
  - 0904-7377-40- 500 TABLET in 1 BOTTLE (0904-7377-40)

0904- Major Pharmaceuticals
- 0904-7377- Hydroxyzine hydrochloride
  - 0904-7377-80- 1000 TABLET in 1 BOTTLE (0904-7377-80)

0904- Major Pharmaceuticals
- 0904-7378- Hydroxyzine hydrochloride
  - 0904-7378-40- 500 TABLET in 1 BOTTLE (0904-7378-40)

0904- Major Pharmaceuticals
- 0904-7378- Hydroxyzine hydrochloride
  - 0904-7378-80- 1000 TABLET in 1 BOTTLE (0904-7378-80)

0904- Major Pharmaceuticals
- 0904-7379- Hydroxyzine hydrochloride
  - 0904-7379-40- 500 TABLET in 1 BOTTLE (0904-7379-40)

0904- Major Pharmaceuticals
- 0904-7379- Hydroxyzine hydrochloride
  - 0904-7379-80- 1000 TABLET in 1 BOTTLE (0904-7379-80)

10135- Marlex Pharmaceuticals, Inc.
- 10135-810- HYDROXYZINE HYDROCHLORIDE
  - 10135-810-01- 100 TABLET, FILM COATED in 1 BOTTLE (10135-810-01)

10135- Marlex Pharmaceuticals, Inc.
- 10135-810- HYDROXYZINE HYDROCHLORIDE
  - 10135-810-10- 1000 TABLET, FILM COATED in 1 BOTTLE (10135-810-10)

10135- Marlex Pharmaceuticals, Inc.
- 10135-811- HYDROXYZINE HYDROCHLORIDE
  - 10135-811-01- 100 TABLET, FILM COATED in 1 BOTTLE (10135-811-01)

10135- Marlex Pharmaceuticals, Inc.
- 10135-811- HYDROXYZINE HYDROCHLORIDE
  - 10135-811-10- 1000 TABLET, FILM COATED in 1 BOTTLE (10135-811-10)

10135- Marlex Pharmaceuticals, Inc.
- 10135-812- HYDROXYZINE HYDROCHLORIDE
  - 10135-812-01- 100 TABLET, FILM COATED in 1 BOTTLE (10135-812-01)

10135- Marlex Pharmaceuticals, Inc.
- 10135-812- HYDROXYZINE HYDROCHLORIDE
  - 10135-812-10- 1000 TABLET, FILM COATED in 1 BOTTLE (10135-812-10)

10702- KVK-Tech, Inc.
- 10702-010- Hydroxyzine Hydrochloride
  - 10702-010-01- 100 TABLET, FILM COATED in 1 BOTTLE (10702-010-01)

10702- KVK-Tech, Inc.
- 10702-010- Hydroxyzine Hydrochloride
  - 10702-010-10- 1000 TABLET, FILM COATED in 1 BOTTLE (10702-010-10)

10702- KVK-Tech, Inc.
- 10702-010- Hydroxyzine Hydrochloride
  - 10702-010-50- 500 TABLET, FILM COATED in 1 BOTTLE (10702-010-50)

10702- KVK-Tech, Inc.
- 10702-011- Hydroxyzine Hydrochloride
  - 10702-011-01- 100 TABLET, FILM COATED in 1 BOTTLE (10702-011-01)

10702- KVK-Tech, Inc.
- 10702-011- Hydroxyzine Hydrochloride
  - 10702-011-10- 1000 TABLET, FILM COATED in 1 BOTTLE (10702-011-10)

10702- KVK-Tech, Inc.
- 10702-011- Hydroxyzine Hydrochloride
  - 10702-011-50- 500 TABLET, FILM COATED in 1 BOTTLE (10702-011-50)

10702- KVK-Tech, Inc.
- 10702-012- Hydroxyzine Hydrochloride
  - 10702-012-01- 100 TABLET, FILM COATED in 1 BOTTLE (10702-012-01)

10702- KVK-Tech, Inc.
- 10702-012- Hydroxyzine Hydrochloride
  - 10702-012-10- 1000 TABLET, FILM COATED in 1 BOTTLE (10702-012-10)

10702- KVK-Tech, Inc.
- 10702-012- Hydroxyzine Hydrochloride
  - 10702-012-50- 500 TABLET, FILM COATED in 1 BOTTLE (10702-012-50)

11534- Sunrise Pharmaceutical, Inc.
- 11534-204- HYDROXYZINE HYDROCHLORIDE
  - 11534-204-01- 100 TABLET, FILM COATED in 1 BOTTLE (11534-204-01)

11534- Sunrise Pharmaceutical, Inc.
- 11534-204- HYDROXYZINE HYDROCHLORIDE
  - 11534-204-03- 1000 TABLET, FILM COATED in 1 BOTTLE (11534-204-03)

11534- Sunrise Pharmaceutical, Inc.
- 11534-204- HYDROXYZINE HYDROCHLORIDE
  - 11534-204-04- 500 TABLET, FILM COATED in 1 BOTTLE (11534-204-04)

11534- Sunrise Pharmaceutical, Inc.
- 11534-205- HYDROXYZINE HYDROCHLORIDE
  - 11534-205-01- 100 TABLET, FILM COATED in 1 BOTTLE (11534-205-01)

11534- Sunrise Pharmaceutical, Inc.
- 11534-205- HYDROXYZINE HYDROCHLORIDE
  - 11534-205-03- 1000 TABLET, FILM COATED in 1 BOTTLE (11534-205-03)

11534- Sunrise Pharmaceutical, Inc.
- 11534-205- HYDROXYZINE HYDROCHLORIDE
  - 11534-205-04- 500 TABLET, FILM COATED in 1 BOTTLE (11534-205-04)

11534- Sunrise Pharmaceutical, Inc.
- 11534-206- HYDROXYZINE HYDROCHLORIDE
  - 11534-206-01- 100 TABLET, FILM COATED in 1 BOTTLE (11534-206-01)

11534- Sunrise Pharmaceutical, Inc.
- 11534-206- HYDROXYZINE HYDROCHLORIDE
  - 11534-206-03- 1000 TABLET, FILM COATED in 1 BOTTLE (11534-206-03)

11534- Sunrise Pharmaceutical, Inc.
- 11534-206- HYDROXYZINE HYDROCHLORIDE
  - 11534-206-04- 500 TABLET, FILM COATED in 1 BOTTLE (11534-206-04)

13746- Srikem Laboratories Pvt. Ltd.
- 13746-103-
  - 13746-103-01- 25 kg in 1 CONTAINER (13746-103-01)

14593- Emcure Pharmaceuticals Limited
- 14593-950-
  - 14593-950-01- 50 kg in 1 DRUM (14593-950-01)

14593- Emcure Pharmaceuticals Limited
- 14593-950-
  - 14593-950-02- 15 kg in 1 DRUM (14593-950-02)

14593- Emcure Pharmaceuticals Limited
- 14593-950-
  14593-950-03- 1 kg in 1 POUCH (14593-950-03)

14593- Emcure Pharmaceuticals Limited
- 14593-950-
  14593-950-04- 6 kg in 1 DRUM (14593-950-04)

16571- Rising Pharma Holdings, Inc.
- 16571-113- HYDROXYZINE HYDROCHLORIDE
  16571-113-01- 100 TABLET, FILM COATED in 1 BOTTLE (16571-113-01)

16571- Rising Pharma Holdings, Inc.
- 16571-113- HYDROXYZINE HYDROCHLORIDE
  - 16571-113-50- 500 TABLET, FILM COATED in 1 BOTTLE (16571-113-50)

16571- Rising Pharma Holdings, Inc.
- 16571-114- HYDROXYZINE HYDROCHLORIDE
  - 16571-114-01- 100 TABLET, FILM COATED in 1 BOTTLE (16571-114-01)

16571- Rising Pharma Holdings, Inc.
- 16571-114- HYDROXYZINE HYDROCHLORIDE
  - 16571-114-10- 1000 TABLET, FILM COATED in 1 BOTTLE (16571-114-10)

16571- Rising Pharma Holdings, Inc.
- 16571-114- HYDROXYZINE HYDROCHLORIDE
  - 16571-114-50- 500 TABLET, FILM COATED in 1 BOTTLE (16571-114-50)

16571- Rising Pharma Holdings, Inc.
- 16571-115- HYDROXYZINE HYDROCHLORIDE
  - 16571-115-01- 100 TABLET, FILM COATED in 1 BOTTLE (16571-115-01)

16571- Rising Pharma Holdings, Inc.
- 16571-115- HYDROXYZINE HYDROCHLORIDE
  - 16571-115-10- 1000 TABLET, FILM COATED in 1 BOTTLE (16571-115-10)

16571- Rising Pharma Holdings, Inc.
- 16571-115- HYDROXYZINE HYDROCHLORIDE
  - 16571-115-50- 500 TABLET, FILM COATED in 1 BOTTLE (16571-115-50)

16714- Northstar RxLLC
- 16714-081- HydrOXYzine Hydrochloride
  - 16714-081-10- 100 TABLET in 1 BOTTLE (16714-081-10)

16714- Northstar RxLLC
- 16714-081- HydrOXYzine Hydrochloride
  - 16714-081-11- 500 TABLET in 1 BOTTLE (16714-081-11)

16714- Northstar RxLLC
- 16714-082- HydrOXYzine Hydrochloride
  - 16714-082-10- 100 TABLET in 1 BOTTLE (16714-082-10)

16714- Northstar RxLLC
- 16714-082- HydrOXYzine Hydrochloride
  - 16714-082-11- 500 TABLET in 1 BOTTLE (16714-082-11)

16714- Northstar RxLLC
- 16714-082- HydrOXYzine Hydrochloride
  - 16714-082-12- 1000 TABLET in 1 BOTTLE (16714-082-12)

16714- Northstar RxLLC
- 16714-083- HydrOXYzine Hydrochloride
  - 16714-083-10- 100 TABLET in 1 BOTTLE (16714-083-10)

16714- Northstar RxLLC
- 16714-083- HydrOXYzine Hydrochloride
  - 16714-083-11- 500 TABLET in 1 BOTTLE (16714-083-11)

17856- ATLANTIC BIOLOGICALS CORP.
- 17856-0507- Hydroxyzine Hydrochloride
  - 17856-0507-1- 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0507-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0507-2)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-500- Hydroxyzine hydrochloride
  - 23155-500-01- 100 TABLET in 1 BOTTLE (23155-500-01)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-500- Hydroxyzine hydrochloride
  - 23155-500-05- 500 TABLET in 1 BOTTLE (23155-500-05)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-500- Hydroxyzine hydrochloride
  - 23155-500-10- 1000 TABLET in 1 BOTTLE (23155-500-10)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-501- Hydroxyzine hydrochloride
  - 23155-501-01- 100 TABLET in 1 BOTTLE (23155-501-01)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-501- Hydroxyzine hydrochloride
  - 23155-501-05- 500 TABLET in 1 BOTTLE (23155-501-05)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-501- Hydroxyzine hydrochloride
  - 23155-501-10- 1000 TABLET in 1 BOTTLE (23155-501-10)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-502- Hydroxyzine hydrochloride
  - 23155-502-01- 100 TABLET in 1 BOTTLE (23155-502-01)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-502- Hydroxyzine hydrochloride
  - 23155-502-05- 500 TABLET in 1 BOTTLE (23155-502-05)

23155- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-502- Hydroxyzine hydrochloride
  - 23155-502-10- 1000 TABLET in 1 BOTTLE (23155-502-10)

24234- Glochem Industries Private Limited
- 24234-0015-
  - 24234-0015-0- 25 kg in 1 DRUM (24234-0015-0)

24658- PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
- 24658-781- Hydroxyzine Hydrochloride
  24658-781-05- 500 TABLET, FILM COATED in 1 BOTTLE (24658-781-05)

24658- PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
- 24658-781- Hydroxyzine Hydrochloride
  - 24658-781-10- 1000 TABLET, FILM COATED in 1 BOTTLE (24658-781-10)

24658- PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
- 24658-782- Hydroxyzine Hydrochloride
  - 24658-782-10- 1000 TABLET, FILM COATED in 1 BOTTLE (24658-782-10)

24658- PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
- 24658-783- Hydroxyzine Hydrochloride
  - 24658-783-10- 1000 TABLET, FILM COATED in 1 BOTTLE (24658-783-10)

31722- Camber Pharmaceuticals, Inc.
- 31722-500- Hydroxyzine Hydrochloride
  - 31722-500-01- 100 TABLET, FILM COATED in 1 BOTTLE (31722-500-01)

31722- Camber Pharmaceuticals, Inc.
- 31722-500- Hydroxyzine Hydrochloride
  - 31722-500-05- 500 TABLET, FILM COATED in 1 BOTTLE (31722-500-05)

31722- Camber Pharmaceuticals, Inc.
- 31722-500- Hydroxyzine Hydrochloride
  - 31722-500-10- 1000 TABLET, FILM COATED in 1 BOTTLE (31722-500-10)

31722- Camber Pharmaceuticals, Inc.
- 31722-501- Hydroxyzine Hydrochloride
  - 31722-501-01- 100 TABLET, FILM COATED in 1 BOTTLE (31722-501-01)

31722- Camber Pharmaceuticals, Inc.
- 31722-501- Hydroxyzine Hydrochloride
  - 31722-501-05- 500 TABLET, FILM COATED in 1 BOTTLE (31722-501-05)

31722- Camber Pharmaceuticals, Inc.
- 31722-501- Hydroxyzine Hydrochloride
  - 31722-501-10- 1000 TABLET, FILM COATED in 1 BOTTLE (31722-501-10)

31722- Camber Pharmaceuticals, Inc.
- 31722-502- Hydroxyzine Hydrochloride
  - 31722-502-01- 100 TABLET, FILM COATED in 1 BOTTLE (31722-502-01)

31722- Camber Pharmaceuticals, Inc.
- 31722-502- Hydroxyzine Hydrochloride
  - 31722-502-05- 500 TABLET, FILM COATED in 1 BOTTLE (31722-502-05)

31722- Camber Pharmaceuticals, Inc.
- 31722-502- Hydroxyzine Hydrochloride
  - 31722-502-10- 1000 TABLET, FILM COATED in 1 BOTTLE (31722-502-10)

38779- Medisca Inc.
- 38779-0298-
  - 38779-0298-4- 25 g in 1 JAR (38779-0298-4)

38779- Medisca Inc.
- 38779-0298-
  38779-0298-5- 100 g in 1 JAR (38779-0298-5)

38779- Medisca Inc.
- 38779-0298-
  38779-0298-7- 25000 g in 1 DRUM (38779-0298-7)

38779- Medisca Inc.
- 38779-0298-
  38779-0298-8- 500 g in 1 JAR (38779-0298-8)

38779- Medisca Inc.
- 38779-0298-
  38779-0298-9- 1000 g in 1 JAR (38779-0298-9)

42806- Epic Pharma, LLC
- 42806-159- Hydroxyzine Hydrochloride
  42806-159-01- 100 TABLET, FILM COATED in 1 BOTTLE (42806-159-01)

42806- Epic Pharma, LLC
- 42806-159- Hydroxyzine Hydrochloride
  - 42806-159-05- 500 TABLET, FILM COATED in 1 BOTTLE (42806-159-05)

section name header

Pronunciation ⬇

Classifications ⬆ ⬇

Indications ⬆ ⬇

Action ⬆ ⬇

Pharmacokinetics ⬆ ⬇

Time/Action Profile ⬆ ⬇

Contraind./Precautions ⬆ ⬇

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Canadian Brand Names ⬆ ⬇

Code ⬆